Robert J. Cardnell
0009-0005-6203-0234
Publication & Citation Trends
Publications
0 total
Abstract 4127: Inferring transcriptomic programs from circulating tumor DNA methylation signatures in small cell lung cancer using RRBS and EM-seq
Cited by 0
Semantic Scholar
Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer
Cited by 0
Semantic Scholar
Abstract 4546: HER2- and TROP2-antibody-drug conjugates in small cell lung cancer cell lines and 3D culture: Efficacy and role of target expression
Cited by 0
Semantic Scholar
P2.06.84 Tracking Ctc Phenotypes in SCLC Liquid Biopsies as a Diagnostic and Therapy Response Assessment Tool
Cited by 0
Semantic Scholar
Abstract 3279: Smoking burden is associated with immunotherapy resistance in extensive stage small cell lung cancer
Cited by 0
Semantic Scholar
CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level
Cited by 1
Semantic Scholar
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer OA
Cited by 6
Semantic Scholar
Evaluating Therapeutic Marker Expression and EMT Heterogeneity in Circulating Tumor Cells from SCLC Liquid Biopsies using Mass Cytometry
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Research Studies
(89)
Phagocytosis and Immune Regulation
(57)
Pancreatic and Hepatic Oncology Research
(44)
Neuroendocrine Tumor Research Advances
(36)
Microtubule and mitosis dynamics
(33)
Affiliations
Northwestern University
The University of Texas MD Anderson Cancer Center
Virginia Commonwealth University
Tolero Pharmaceuticals (United States)
Astex Pharmaceuticals